Clinical Trial Update: A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

View source ↗

Summary

A pivotal Phase 3 trial evaluating the safety and effectiveness of arformoterol in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Arformoterol (Brovana) (arformoterol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: COPD | Phase 3 | Status: COMPLETED